Aveanna Healthcare (NASDAQ:AVAH) Sets New 52-Week High – Should You Buy?

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $5.99 and last traded at $5.87, with a volume of 202219 shares changing hands. The stock had previously closed at $5.59.

Wall Street Analyst Weigh In

Several research firms recently commented on AVAH. UBS Group increased their price target on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a report on Friday, August 9th. Royal Bank of Canada lifted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a report on Friday, August 9th.

Aveanna Healthcare Stock Up 4.3 %

The business’s 50-day simple moving average is $5.13 and its two-hundred day simple moving average is $3.94. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of -8.83 and a beta of 2.13.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million during the quarter, compared to analyst estimates of $494.02 million. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.09 earnings per share for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds have recently bought and sold shares of the company. Littlejohn & Co. LLC lifted its position in shares of Aveanna Healthcare by 7.4% during the first quarter. Littlejohn & Co. LLC now owns 8,377,258 shares of the company’s stock worth $20,859,000 after purchasing an additional 578,488 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after buying an additional 44,970 shares in the last quarter. Acadian Asset Management LLC boosted its position in Aveanna Healthcare by 185.6% in the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after buying an additional 19,096 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Aveanna Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after acquiring an additional 9,243 shares in the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after acquiring an additional 96,600 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.